ARTG Entry
TABRECTA
ARTG entry for TABRECTA (capmatinib hydrochloride), ARTG 489646 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Novartis Pharmaceuticals
- Active ingredient: capmatinib hydrochloride
- Therapeutic area: Oncology